'I'm sure it's cost and cost alone': B.C. only province in Canada that won't cover multiple sclerosis drug
Cranbook teacher Andrea Rollheiser was 32 years old when she first had symptoms of optic neuritis. But it was three years before she was officially diagnosed with relapsing remitting multiple sclerosis, or RRMS.
“The diagnosis itself definitely explained a lot of symptoms and things I have felt over the years,” said Rollheiser, who is now 42-years-old and on medical leave from her teaching position.
After a serious relapse impacted her mobility and landed her in hospital last year, she learned about a drug that could lessen the number and severity of future relapses.
“So that drug is Ocrevus. And Ocrevus is not approved in B.C. for use in patients with RRMS. It is approved for patients with primary progressive MS. That is not me,” said Rollheiser.
Every other province and territory covers Ocrevus, which has been approved by Health Canada and gone through two large-scale clinical trials for relapsing remitting MS patients. But B.C. pharmacare won’t cover it.
“They replace it with one of these generic medications which has actually never been tested in proper control studies for multiple sclerosis,” said Dr. Freedman, director of the MS research unit at Ottawa Hospital. “I’m sure it’s cost and cost alone that is driving B.C. Pharmacare to make this decision.”
In a statement, the B.C. health ministry said: “The national Common Drug Review evaluates a drug based on its therapeutic value and cost effectiveness and makes recommendations to provincial drug plans. B.C.’s Drug Benefit Council then takes that recommendation into consideration when reviewing the drug and makes its own recommendation to the ministry.”
Rollheiser said the decision not to cover Ocrevus could have dire consequences for British Columbians like her.
“I was told my next relapse will be most likely severe again. That there needs to be intervention, there needs to be drug intervention,” she said.
Her private insurance won’t cover the twice a year Ocrevus infusions, and like most MS patients, she can’t afford the out-of-pocket cost of $33,000.
“And it’s frustrating to know that just a province over, I could be covered and be on this drug,” said Rollheiser.
Dr. Freedman believes every RRMS patient in Canada should have access to the Ocrevus.
“My colleagues have exhausted themselves writing to government and pleading for the use of the approved therapies, so I think it’s got to come from the grass roots, it’s got to be the people,” Freedman said.
That’s why Rollheiser is speaking out, hoping her story convinces the B.C. government to take another look at Ocrevus.
“These drugs are expensive, however every other province and territory has approved them for use with their MS patients,” she said. “It is very hard to think this is 2023, that this is Canada, and that my quality of my future life is being effected today by not being on these drugs.
CTVNews.ca Top Stories
Widow looking for answers after Quebec man dies in Texas Ironman competition
The widow of a Quebec man who died competing in an Ironman competition is looking for answers.
Tom Mulcair: Park littered with trash after 'pilot project' is perfect symbol of Trudeau governance
Former NDP leader Tom Mulcair says that what's happening now in a trash-littered federal park in Quebec is a perfect metaphor for how the Trudeau government runs things.
World seeing near breakdown of international law amid wars in Gaza and Ukraine, Amnesty says
The world is seeing a near breakdown of international law amid flagrant rule-breaking in Gaza and Ukraine, multiplying armed conflicts, the rise of authoritarianism and huge rights violations in Sudan, Ethiopia and Myanmar, Amnesty International warned Wednesday as it published its annual report.
Photographer alleges he was forced to watch Megan Thee Stallion have sex and was unfairly fired
A photographer who worked for Megan Thee Stallion said in a lawsuit filed Tuesday that he was forced to watch her have sex, was unfairly fired soon after and was abused as her employee.
Amid concerns over 'collateral damage' Trudeau, Freeland defend capital gains tax change
Facing pushback from physicians and businesspeople over the coming increase to the capital gains inclusion rate, Prime Minister Justin Trudeau and his deputy Chrystia Freeland are standing by their plan to target Canada's highest earners.
U.S. Senate passes bill forcing TikTok's parent company to sell or face ban, sends to Biden for signature
The Senate passed legislation Tuesday that would force TikTok's China-based parent company to sell the social media platform under the threat of a ban, a contentious move by U.S. lawmakers that's expected to face legal challenges.
Wildfire southwest of Peace River spurs evacuation order
People living near a wildfire burning about 15 kilometres southwest of Peace River are being told to evacuate their homes.
U.S. Senate overwhelmingly passes aid for Ukraine, Israel and Taiwan with big bipartisan vote
The U.S. Senate has passed US$95 billion in war aid to Ukraine, Israel and Taiwan, sending the legislation to President Joe Biden after months of delays and contentious debate over how involved the United States should be in foreign wars.
'My stomach dropped': Winnipeg man speaks out after being criminally harassed following single online date
A Winnipeg man said a single date gone wrong led to years of criminal harassment, false arrests, stress and depression.